LOX and breast carcinoma: siRNA knockdown of LOX or inhibition with BAPN in human MDA-MB-231 breast cancer cells reduced hypoxia-driven invasion in nude mice, demonstrating a clear role for LOX in hypoxia-driven metastasis [91].